Summit Therapeutics Inc. (SMMT) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$19,395
Total Return
93.95%
CAGR
14.17%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +8.55% |
| Median | -0.82% |
| Best | +635.29% |
| Worst | -64.18% |
| % of Windows Positive | 48.2% |
1-Year (252 Trading Days)
| Average | +169.57% |
| Median | +66.80% |
| Best | +1598.40% |
| Worst | -88.86% |
| % of Windows Positive | 62.7% |
3-Year (756 Trading Days)
| Average | +956.34% |
| Median | +781.68% |
| Best | +2913.66% |
| Worst | -9.61% |
| % of Windows Positive | 99.2% |
Risk Metrics
| Maximum Drawdown | -91.78% |
| Average Drawdown | -52.98% |
| Drawdown Duration | 692 Trading Days |
| Sortino Ratio | 1.62 |
| Calmar Ratio | 0.15 |
| CVaR (5%) | -15.22% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -13.84% (-29.76% ann.) | $1383.65 | $0.00 | $0.00 | $0.00 |
| 2025 | -1.99% | $198.93 | $0.00 | $0.00 | $0.00 |
| 2024 | +583.72% | +$58371.78 | $0.00 | $0.00 | $0.00 |
| 2023 | -38.59% | $3858.84 | $0.00 | $0.00 | $0.00 |
| 2022 | +57.99% | +$5799.29 | $0.00 | $0.00 | $0.00 |
| 2021 | -42.77% | $4276.61 | $0.00 | $0.00 | $0.00 |
| 2020 | +193.75% | +$19374.97 | $0.00 | $0.00 | $0.00 |
| 2019 | +39.13% | +$3913.04 | $0.00 | $0.00 | $0.00 |
| 2018 | -89.62% | $8962.09 | $0.00 | $0.00 | $0.00 |
| 2017 | +29.44% | +$2943.93 | $0.00 | $0.00 | $0.00 |
| 2016 | -25.57% | $2556.52 | $0.00 | $0.00 | $0.00 |
| 2015 partial | +12.86% (+15.81% ann.) | +$1285.57 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | March 5, 2015 – February 19, 2020 | -85.77% | -32.50% | $8577.04 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | +42.07% | +5403.63% | +$4206.93 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +53.30% | +98.86% | +$5330.19 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +53.50% | +50.16% | +$5349.53 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -80.71% | -82.57% | $8070.86 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +2522.01% | +482.60% | +$252201.15 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -38.64% | -24.90% | $3864.01 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.